JA Saúde Animal
JA Saúde Animal is a Brazilian veterinary pharmaceutical manufacturer founded in 2002, developing and commercializing over 40 medications across eight therapeutic categories for cattle, swine, equines, goats, and sheep, serving producers, veterinarians, and agricultural retailers domestically and exporting to Latin America and Africa.
- Company typePrivate
- Founded2002
- HeadquartersPatrocínio Paulista, Brazil
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What JA Saúde Animal does
JA Saúde Animal is a Brazilian veterinary pharmaceutical manufacturer founded in 2002 by Prof. Dr. José Abdo de Andrade Hellu and headquartered in Patrocínio Paulista, São Paulo. The company researches, develops, manufactures, and commercializes veterinary medications for cattle (dairy and beef), swine, equines, goats, and sheep, with a portfolio of more than 40 products organized across eight therapeutic categories: specialties, anesthetics, anti-inflammatories, antimicrobials, antiparasitics, fortifiers/nutritional supplements, intramammary treatments, and reproduction hormones. Flagship brands include Duplatak, Eprigold, Mastclin, BLOC, Pró-Bezerro, Cetofur, and Turbocálcio, with formulations delivered via injectable, intramammary, pour-on, and oral routes.
The operating model is vertically integrated: JA maintains an internal pharmaceutical and veterinary R&D department, physical-chemical and microbiological quality-control laboratories, MAPA-authorized manufacturing for injectable and non-injectable medications, and an experimental farm center (Fazenda Pedrinhas). Its stated technical differentiator is the development of novel associations of existing active principles with dosages adjusted to Brazilian herd profile, climate, and sanitary conditions — a positioning that has earned five consecutive years (2022–2026) on the Financial Times Americas' Fastest Growing Companies list. R&D is reinforced through alliances with EMBRAPA, CNPq, BNDES (first veterinary company approved in 2008), USP, UFG, UFT, UFSM, and FAZU.
Revenue mechanics are B2B and quote-based. Domestically, products reach end users through agricultural stores (lojistas agro), an internal field-sales commercial team active throughout Brazil, and a proprietary e-commerce storefront (loja.jasaudeanimal.com.br), with brand and demand-generation supported by trade events (Acricorte, ExpoZebu, Megaleite, Cooprata, ABRAVEQ), a mobile app (JA APP), technical blog content, webinars, and the JA Online video series. Exports are managed by a dedicated Foreign Trade department (COMEX) under the "Innovation crossing borders" banner into Latin America, Africa, and adjacent regions, formalized since 2017 through the ABCZ/ApexBrasil Brazilian Cattle consortium. The company operates as a privately held Sociedade Anônima (JA Saúde Animal S.A.), founder-controlled, with one disclosed institutional equity round (Axxon Group, approximately $18.7M in November 2021) and additional debt funding via Notas Comerciais.
JA Saúde Animal firmographics
Firmographics- Name
- JA Saúde Animal
- Legal name
- JA SAÚDE ANIMAL S.A.
- Website
- https://jasaudeanimal.com.br
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- JA Saúde Animal is a Brazilian veterinary pharmaceutical manufacturer founded in 2002, developing and commercializing over 40 medications across eight therapeutic categories for cattle, swine, equines, goats, and sheep, serving producers, veterinarians, and agricultural retailers domestically and exporting to Latin America and Africa.
- Ownership category
- akta.pro rank
JA Saúde Animal industry classification
Industry- Product category
- Veterinary Pharmaceuticals
- NAICS
- Livestock Merchant Wholesalers (424520), Livestock Merchant Wholesalers (42452)
- SIC
- Pharmaceutical Preparations (2834), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB)
- akta.pro secondary industries
- Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm) (HLAMAEAD), Antimicrobials & Anti-infectives (HLAMAEAE), Pain Management, Anesthesia & Critical Care Drugs (HLAMAEAF)
Keywords
Where JA Saúde Animal is headquartered
LocationHeadquarters
- HQ city
- Patrocínio Paulista
- HQ country
- Brazil
- HQ region
- Latin America
Offices2 records
Markets served
JA Saúde Animal business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Veterinary Pharmaceutical Products: Sale of veterinary medications including antimicrobials, anti-inflammatories, antiparasitics, anesthetics, fortifiers, intramammaries, and reproduction products for cattle (dairy and beef), swine, equines, goats, and sheep.
Go-to-market motion3 records
Distribution channels4 records
Marketing channels10 records
JA Saúde Animal product offering
Product offeringCore offering
JA Saúde Animal is a 100% Brazilian veterinary pharmaceutical manufacturer that researches, develops, manufactures, and commercializes animal health medications for livestock. Its product portfolio spans eight therapeutic categories (specialties, anesthetics, anti-inflammatories, antimicrobials, antiparasitics, fortifiers/nutritional supplements, intramammary treatments, and reproduction hormones) covering cattle (dairy and beef), swine, equines, goats, and sheep. The company operates a MAPA-authorized manufacturing facility in Patrocínio Paulista, São Paulo, and exports products to Latin America and Africa through a dedicated Foreign Trade department (COMEX).
Product overview
JA Saúde Animal is a Brazilian veterinary pharmaceutical manufacturer founded in 2002 and headquartered in Patrocínio Paulista, São Paulo. The company operates as a single-platform pharmaceutical product portfolio — not a software platform — organized across eight therapeutic categories: Specialties (including Duplatak, Eprigold), Anesthetics (BLOC, Lidocol, EGG PPU, Equisedan, Dettovet), Anti-inflammatories (Doragold, Prador, Diclofenaco JA, Flumax, Dexa-JA, Vetprofen), Antimicrobials (Prontostrep, Vetipen LA, Gentopen, Cetofur, Benzafort 12 Milhões, Diclotril, Vetsulfa, Enro 10, Amox LA, Cursotril, Agrothal, Paracurso, Tormicina 100, Tormicina LA, Pro-Bezerro), Antiparasitics (Duplatak, Eprigold, Trifon 50), Fortifiers/Nutritional Supplements (Calfomag, Catofós B12, Ative A.D.E, Glicoton B12, Probacter Bezerro, Probacter Bov, Adethor, Ferrodex, Ferrodex B12), Intramammary Treatments (Mastclin, Mastite Clínica VL), and Reproduction hormones (Cioton, Lactocina, Metrifim, Benzogest, Profertil, Prolacton). The product range covers multiple livestock species including cattle, pigs, horses, goats, and sheep, with formulations administered via injectable, intramammary, pour-on, and oral routes. The company holds MAPA authorization for manufacturing injectable and non-injectable veterinary medications under Brazilian Good Manufacturing Practices.
Differentiator
Problem solved
Functional benefit
Products and services
- Duplatak A dual-action antiparasitic formulation for cattle, combining two active ingredients to target a broad spectrum of internal parasites.
- Eprigold Contains Eprinomectin, formulated for zero milk-discard applications in lactating dairy cattle, providing endectocide activity against gastrointestinal nematodes and ectoparasites.
- Doragold A non-steroidal anti-inflammatory and analgesic product for cattle, designed to manage pain and inflammation associated with musculoskeletal conditions and surgical procedures.
- Mastclin A cefalosporin-based intramammary antibiotic for the treatment of clinical mastitis in lactating dairy cows.
- Mastite Clínica VL An intramammary veterinary medication for the clinical treatment of mastitis in cattle.
- Probacter Bezerro A probiotic and nutritional supplement specifically formulated for calves, supporting gut health and immune development in neonates.
- Probacter Bov A probiotic supplement for adult cattle, designed to promote rumen function and overall digestive health in bovine herds.
- Calfomag A calcium and magnesium supplement for calves, supporting bone development and preventing mineral deficiencies in neonates.
- Catofós B12 A B-complex and phosphorus supplement containing vitamin B12, formulated to support energy metabolism and prevent nutritional deficiencies in livestock.
- Ative A.D.E A fat-soluble vitamin complex providing vitamins A, D, and E to support immune function, bone health, and reproductive performance in cattle.
- Glicoton B12 A glucose-based supplement with vitamin B12, designed to provide rapid energy support and prevent anemia in livestock.
- Adethor An injectable vitamin and mineral supplement formulated to support metabolic function and recovery in cattle.
- Ferrodex An iron dextran injectable supplement for the prevention and treatment of iron deficiency anemia in piglets and other livestock.
- Ferrodex B12 An iron dextran formulation fortified with vitamin B12, providing hematinic support for piglets and young livestock.
- Cioton A prostaglandin-based luteolytic agent for cattle, used to synchronize estrus cycles and manage reproductive disorders.
- Lactocina An oxytocin-based product for the stimulation of milk let-down and management of postpartum uterine involution in cattle.
- Metrifim A veterinary medication for the treatment of chronic endometritis and uterine infections in cattle, supporting reproductive recovery.
- Benzogest A prostaglandin analogue used for reproductive management in cattle, including estrus synchronization and treatment of pyometra.
- Profertil Contains lyophilized gonadorelin, a GnRH analogue used to induce ovulation and treat ovarian cysts in cattle.
- Prolacton An injectable oxytocin formulation for the induction of milk ejection and management of agalactia in sows and cows.
- Prontostrep A streptomycin-based antimicrobial for the treatment of bacterial infections in livestock, including respiratory and enteric diseases.
- Vetipen LA A long-acting penicillin formulation providing sustained antimicrobial coverage for respiratory and systemic infections in cattle.
- Gentopen A gentamicin-based broad-spectrum antimicrobial for the treatment of Gram-negative bacterial infections in livestock.
- Cetofur A ceftiofur-based antimicrobial for the treatment of bovine respiratory disease and other systemic bacterial infections.
- Benzafort 12 Milhões A high-potency benzathine penicillin formulation for the treatment of Gram-positive bacterial infections in cattle and other species.
- Diclotril A diclofenac-based non-steroidal anti-inflammatory and antimicrobial combination for the treatment of inflammatory conditions with secondary bacterial involvement.
- Vetsulfa A sulfonamide-based antimicrobial for the treatment of respiratory, urinary, and gastrointestinal infections in livestock.
- Enro 10 An enrofloxacin-based fluoroquinolone antimicrobial for the treatment of respiratory and enteric bacterial diseases in cattle and pigs.
- Amox LA A long-acting amoxicillin formulation providing extended antimicrobial coverage for respiratory and soft tissue infections in livestock.
- Cursotril A veterinary antimicrobial formulation for the treatment of bacterial infections in cattle and other production animals.
- Agrothal A thiamphenicol-based antimicrobial for the treatment of respiratory bacterial infections in livestock.
- Paracurso A veterinary antimicrobial indicated for the treatment of enteric and systemic bacterial infections in cattle and swine.
- Tormicina 100 A tulathromycin-based long-acting macrolide antimicrobial for the treatment of bovine and swine respiratory disease.
- Tormicina LA A long-acting formulation of tulathromycin providing extended coverage against respiratory pathogens in cattle.
- Pró-Bezerro A combination product for calves providing both antimicrobial and antiparasitic activity, targeting common neonatal health challenges.
- Trifon 50 A systemic parasiticidal pour-on formulation for cattle, providing broad-spectrum control of internal and external parasites.
- BLOC A lidocaine-based local anesthetic combined with xylazine for sedation and analgesia in cattle and horses during surgical procedures.
- Lidocol A lidocaine-based local anesthetic formulation for inducing local analgesia without the need for sedation, used in minor surgical procedures.
- EGG PPU A ready-to-use guaifenesin-based muscle relaxant formulation for anesthesia induction and maintenance in equines.
- Equisedan A xylazine-based sedative and analgesic for horses, used for chemical restraint and minor surgical procedures.
- Dettovet A detomidine-based sedative and analgesic for horses, providing deep sedation and analgesia for diagnostic and surgical procedures.
- Prador A combination of meloxicam and dipyrone providing anti-inflammatory, analgesic, and antipyretic activity for cattle.
- Diclofenaco JA A diclofenac-based non-steroidal anti-inflammatory drug for the management of inflammation, pain, and fever in cattle.
- Flumax A flunixin-based NSAID for the control of inflammation, pain, and endotoxin-related fever in cattle.
- Dexa-JA A dexamethasone-based corticosteroid anti-inflammatory for the treatment of inflammatory and immune-mediated conditions in livestock.
- Vetprofen A ketoprofen-based NSAID for the management of musculoskeletal inflammation, colic pain, and fever in horses and cattle.
- Turbocálcio A mineral replenisher, energy supplement, and hepatic protector formulated for livestock.
- Imidovet A high-efficacy hemoparasiticide product for cattle.
- Hidralac A hydroelectrolytic and energy replenisher formulated for livestock.
- Rambo Pulverização A spray-on parasiticidal formulation for combating external parasites on livestock.
Companies that use JA Saúde Animal
Customer profileSegments5 records
Ideal customer profiles5 records
JA Saúde Animal technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
JA Saúde Animal partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Brazilian Cattle (ABCZ + ApexBrasil)coreAssociation with Brazilian Cattle project, an initiative of ABCZ (Associação Brasileira dos Criadores de Zebu) in partnership with ApexBrasil, focused on promoting exports of the Brazilian agricultural chain. JA has been associated since 2017.
- CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico)corePartnership with Brazilian technology and innovation research funding council. Supports research and innovation projects in animal health.
- EMBRAPA (Empresa Brasileira de Pesquisa Agropecuária)corePartnership with Brazilian agricultural research corporation for research and innovation in animal health.
- USP (Universidade de São Paulo)coreUniversity partner in the JA Universidade project supporting teaching and research in clinical and surgical areas of large animals.
- UFG (Universidade Federal de Goiás)coreUniversity partner in the JA Universidade project supporting teaching and research in clinical and surgical areas of large animals.
- UFT (Universidade Federal de Tocantins)coreUniversity partner in the JA Universidade project supporting teaching and research in clinical and surgical areas of large animals.
- UFSM (Universidade Federal de Santa Maria)coreUniversity partner in the JA Universidade project supporting teaching and research in clinical and surgical areas of large animals.
- ABCZ (Associação Brasileira dos Criadores de Zebu)corePartnership through Brazilian Cattle project for international promotion of Brazilian cattle and veterinary products. JA participated in ExpoZebu and Zebu Connect Day events.
- FAZU (Faculdades Associadas de Uberaba)minorAcademic partnership for teaching and research in large animal health through JA Universidade project.
Scale indicators5 records
Recent moves6 records
Expansion highlights6 records
JA Saúde Animal competitors and assessment
Company assessmentRegional players
- Dechra Pharmaceuticals: Dechra is a UK-based veterinary pharmaceutical company with strong equine and livestock product lines; though more European-focused, it competes with JA's equine anesthetics/sedatives and selected cattle therapeutics in Latin American export markets.
Emerging players
- Hipra: Hipra is a Spanish veterinary biologics and pharmaceuticals manufacturer expanding across Latin America, with growing overlap to JA's livestock vaccine-adjacent and antimicrobial categories in Brazil and neighboring markets.
Broad incumbents
- Vetoquinol: Vetoquinol is a global veterinary pharmaceutical company with relevant livestock and equine product lines that compete with JA in pain management, antimicrobials, and reproductive categories, with growing Brazilian commercial presence.
- Zoetis: Zoetis is the global leader in animal health with a comprehensive portfolio of livestock pharmaceuticals, vaccines, and diagnostics that directly overlaps JA's antimicrobial, anti-inflammatory, antiparasitic, and reproductive categories in the Brazilian market.
- MSD Animal Health: MSD Animal Health (Merck Animal Health) is a global animal health incumbent with deep presence in Brazilian livestock pharmaceuticals, vaccines, and antiparasitics, competing head-to-head with JA in cattle and swine therapeutics.
- Ceva Santé Animale: Ceva Santé Animale is a global veterinary pharmaceutical company with significant Brazilian operations (including a Ceva Paulínia plant), competing with JA in poultry, swine, and cattle pharmaceuticals, reproduction, and vaccines.
- Boehringer Ingelheim Animal Health: Boehringer Ingelheim Animal Health is a top-tier global animal health player with a broad livestock vaccine and pharmaceutical portfolio, overlapping with JA's bovine respiratory disease, reproductive, and anti-inflammatory product lines in Brazil.
- Elanco Animal Health: Elanco Animal Health is a major global animal health company with cattle, swine, and companion animal products that overlap with JA's therapeutic categories, particularly in anti-inflammatories, antimicrobials, and parasiticides.
Direct peers
- Ouro Fino Saúde Animal: Ouro Fino is a Brazilian veterinary pharmaceutical manufacturer with a comparable product portfolio across livestock therapeutics, antiparasitics, and reproduction hormones, serving the same cattle, swine, and equine segments through agricultural stores and direct sales in Brazil.
- Agener União (União Química): Agener União is the animal health division of União Química, a Brazilian manufacturer offering livestock and companion animal pharmaceuticals with overlapping product categories (antimicrobials, anti-inflammatories, parasiticides) and similar distribution through agro retail and veterinarians in Brazil.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat4 records
Customer concentration
JA Saúde Animal financial estimates
Financial estimateRevenue estimate
Valuation estimate
JA Saúde Animal leadership team
Management profileNumber of profiles
Profiles2 records
JA Saúde Animal funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
JA Saúde Animal M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about JA Saúde Animal
What does JA Saúde Animal do?
JA Saúde Animal is a 100% Brazilian veterinary pharmaceutical manufacturer that researches, develops, manufactures, and commercializes animal health medications for livestock. Its product portfolio spans eight therapeutic categories (specialties, anesthetics, anti-inflammatories, antimicrobials, antiparasitics, fortifiers/nutritional supplements, intramammary treatments, and reproduction hormones) covering cattle (dairy and beef), swine, equines, goats, and sheep. The company operates a MAPA-authorized manufacturing facility in Patrocínio Paulista, São Paulo, and exports products to Latin America and Africa through a dedicated Foreign Trade department (COMEX).
Is JA Saúde Animal a public or private company?
JA Saúde Animal is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was JA Saúde Animal founded?
JA Saúde Animal was founded in 2002. It employs 501 to 1,000 people.
Where is JA Saúde Animal based?
JA Saúde Animal is headquartered in Patrocínio Paulista, Brazil, in the Latin America region.
How does JA Saúde Animal make money?
One revenue line is on record: veterinary Pharmaceutical Products.
Who are JA Saúde Animal's main competitors?
Dechra Pharmaceuticals is listed as a regional player. Hipra is listed as an emerging player. Broad incumbents are Vetoquinol, Zoetis, MSD Animal Health, Ceva Santé Animale, Boehringer Ingelheim Animal Health and Elanco Animal Health. Direct peers are Ouro Fino Saúde Animal and Agener União (União Química).
Does JA Saúde Animal have an API?
No public API is recorded for JA Saúde Animal.
What industry is JA Saúde Animal in?
JA Saúde Animal's product category is Veterinary Pharmaceuticals. Its primary akta.pro industry code is HLAMAEAB, Livestock & Production Animal Therapeutics (Rx), with a secondary code of HLAMAEAD, Parasiticides & Ectoparasite Control (Flea/Tick/Heartworm). Its NAICS code is 424520 and its SIC code is 2834.